Qu B, Miskey C, Gömer A, Kleinert RDV, Ibanez SC, Eberle R, Ebenig A, Postmus D, Nocke MK, Herrmann M, Itotia TK, Herrmann ST, Heinen N, Höck S, Hastert FD, von Rhein C, Schürmann C, Li X, van Zandbergen G, Widera M, Ciesek S, Schnierle BS, Tarr AW, Steinmann E, Goffinet C, Pfaender S, Locker JK, Mühlebach MD, Todt D, Brown RJP (2024). TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution. Proc Natl Acad Sci U S A. 121/2024;
PubMed
Khanal R, Heinen N, Bogomolova A, Meister TL, Herrmann ST, Westhoven S, Nocke MK, Todt D, Jockenhövel F, Klein IM, Hartmann L, Vondran FWR, Steinmann E, Zimmer G, Ott M, Brown RJP, Sharma AD, Pfaender S (2024). MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2. Liver Int. 44/2024;
PubMed
Kühn D, Heinen N, Sutter K, Herrmann ST, Nocke MK, Todt D, Burbelo PD, Steinmann E, Ziehe D, Koos B, Adamzik M, Putensen C, Zarbock A, Gravemann U, Jork C, Pfaender S, (2024). Divergent autoantibody and cytokine levels in COVID-19 sepsis patients influence survival. J Med Virol. 96/2024;
PubMed
